ADMT ADM TRONICS UNLIMITED, INC. OTC · United States

ADM TRONICS UNLIMITED, INC. (ADMT) news

ADM TRONICS UNLIMITED, INC. is a public biotech or pharmaceutical company listed on OTC under the ticker ADMT, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest ADM TRONICS UNLIMITED, INC. news

We have not published a story on ADM TRONICS UNLIMITED, INC. yet. When there is news, it will appear here.

ADM TRONICS UNLIMITED, INC. annual financials

Line	FY ended Mar 31, 2026	FY ended Mar 31, 2025
Research and development	$544,971	$517,275
Net income (loss)	-$100,374	-$123,056
Cash from operations	-$124,059	$9,978
Cash and equivalents	$255,730	$382,969

Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $222,619.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about ADM TRONICS UNLIMITED, INC.

What is the ticker symbol of ADM TRONICS UNLIMITED, INC.?

ADM TRONICS UNLIMITED, INC. trades under the ticker ADMT on OTC.

Where is ADM TRONICS UNLIMITED, INC. listed?

ADM TRONICS UNLIMITED, INC. is listed on OTC.

Which country or territory is ADM TRONICS UNLIMITED, INC. listed under?

Our directory records ADM TRONICS UNLIMITED, INC. under United States.

Does aibio.space cover ADM TRONICS UNLIMITED, INC.?

aibio.space lists ADM TRONICS UNLIMITED, INC. among 2,820 public biotech companies and publishes its news here as stories appear.

Is ADM TRONICS UNLIMITED, INC. profitable?

ADM TRONICS UNLIMITED, INC. reported a net loss of $100,374 for the fiscal year ended Mar 31, 2026, and used $124,059 of cash in operations, per its annual report to the SEC.

How much does ADM TRONICS UNLIMITED, INC. spend on research and development?

$544,971 in the fiscal year ended Mar 31, 2026, per its annual report.

How much cash does ADM TRONICS UNLIMITED, INC. have?

$222,619 in cash at Jun 30, 2026, per its 10-Q.

Investor discussion: ADM TRONICS UNLIMITED, INC.

Members talk about ADM TRONICS UNLIMITED, INC. (ADMT). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at ADM TRONICS UNLIMITED, INC., newest first. Each line links the filing it comes from.

Oct 30, 2026Financings
Reported a financing. SEC Form 8-K (Items 1.01,3.02,5.02,7.01,9.01). Source
Aug 14, 2026Distress
Told the SEC a periodic report would be filed late. SEC Form NT 10-Q. Source
Jul 10, 2026Distress
Reported substantial doubt about its ability to continue as a going concern. SEC Form 10-K. Source
Jun 29, 2026Distress
Told the SEC a periodic report would be filed late. SEC Form NT 10-K. Source

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open OTC:ADMT on TradingView.

Listing details

Company: ADM TRONICS UNLIMITED, INC.
Ticker: ADMT
Listing: OTC
Country or territory: United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction